Emdeon

Blackstone Group (NYSE: BX) has signed a definitive agreement to take health-care payment services company Emdeon (NYSE: EM) private in a transaction valued at about $3 billion. Blackstone will pay $19 a share for the Nashville, Tenn., company; the stock closed Thursday at $18.35. Debt financing...

Piper Jaffray is out with its report on Emdeon (NYSE: EM), maintaining Neutral. In a note to clients, Piper Jaffray writes, "The company hosted an investor summit in New York earlier today which provided detailed presentations about different business segments and management's vision for 2015 and...

Citi is out with its report today on Emdeon Inc. (NYSE: EM), raising its price target from $15 to $16. In a note to clients, Citi writes, "We are maintaining our Hold rating. While management reported a solid quarter, we are left looking for more meaningful catalysts. We are raising our target...

Citigroup has raised the price target on Emdeon Inc. (NYSE: EM) from $15 to $16 and maintains its Hold rating.

In a report published by Piper Jaffray, Emdeon's (NYSE: EM) acquisitions are critical for growth. Piper Jaffray said that Emdeon's Q4 numbers were mixed. “Revs below our estimate but EPS in line. Full quarter of Chamberlin acquisition revenues helped the company report decent numbers. While the...

Morgan Stanley made the following rating changes this morning: Quest Diagnostics (NYSE: DGX) from Underweight to Equal-weight. Morgan Stanley writes, "We are upgrading DGX shares to Equal-weight. Our new rating reflects a more stable utilization environment as we assume volumes have largely...

This morning, Jefferies & Company said that it is reiterating its Buy rating and $18 price target on shares of Emdeon Inc. (NYSE: EM). “A rather unremarkable quarter, but recent acquisitions appear on track and poised to contribute meaningfully to growth going forward,” Jefferies & Company...